The company plans to introduce this system to the German market in the fourth quarter of this year. Read More

The development of the product was funded by HHS’ Administration for Strategic Preparedness and Response as well as the Biomedical Advanced Research and Development Authority. Read More

Clinical studies with Comirnaty Original/Omicron BA.4-5 are ongoing. Read More

Nearly 145 million people worldwide experienced symptoms during that timeframe. Read More

The product is the first guanidine-free molecular transport medium, FDA-cleared device available in the U.S. Read More

With these new EUAs in place, FDA has decided to no longer authorize the monovalent mRNA COVID-19 booster doses. Read More

The blood test showed more than 90 percent accuracy in a validation study. Read More

In the midst of a pandemic, if you wait for all the data to come in, “you’ve missed the boat,” said FDA Commissioner Robert Califf yesterday regarding the agency authorizing both Pfizer/BioNTech’s and Moderna’s bivalent COVID-19 boosters before any clinical trials on them are complete. Read More

The vaccine demonstrated 80 percent efficacy against the Delta variant of the SARS-CoV-2 virus. Read More

Unlike some multiple-dose vials, the single-dose vaccine must not be diluted. Read More

The updated booster shot may offer broader and more durable protection against COVID-19, the company said. Read More

Pending authorization, the Omicron BA.4/BA.5-adapted bivalent vaccine will be available to ship immediately, the companies said. Read More